Health Condition 1: null- (1) Positive biopsy finding in one or both breast. (2) Age between 18 to 75 years. (3) Require Neoadjuvant chemotherapy(NACT).
Conditions
Interventions
Intervention1: PET CT: Manufacturer: Philips
Model: Gyroscan
Intervention2: Breast Ultrasound: Manufacturer 1: GE
Model: S8
Manufacturer 2: Philips
Model: IU22
Intervention3: Breast Thermography: Model:illumina360 Description:Rotational thermography unit for breast screening. This is required to image the breast in 360 degree views without involv
Model: S8 Manufacturer 2: Philips
Model: IU22
This is required to compare the findings from thermography with the standard examination results from ultrasound.
Control Intervention2: PET CT: Manufacturer: Philips Model: Gyroscan
This
Sponsors
Cura health care Pvt ltd
Eligibility
Inclusion criteria
Inclusion criteria: (1)Positive biopsy finding in one or both the breasts. (2) Age between 18 to 75 years. (3) Patients who can follow the instructions. (4)Age group â?? 18 years to 75 years (5)Sex - Female (6)Willingness to participate in the study. (7)Patients who can understand the procedure.
Exclusion criteria
Exclusion criteria: (1) Whose clinical condition does not support them lying prone during examination. (2) Any infection in the breast that can spread by air or by contact with the patient table. (3) Who have body fluid discharge in breast. (4) Patients in a medical state who cannot follow explanations given by the clinician to participate in the study. (5) Undergone procedure such as EMG, TENS, physical therapy, chiropractic, and any deep heat treatments 24 hours before the exam. (6) Consumption of alcohol 12 hours prior to the exam. (7) Work out/ exercise in last 4 hours before the exam. (8) Bathing in last 1 hour from the exam. (9) Usage of heat or cold packs on the day of the exam. (10) Use of skin creams, perfume, powders or deodorants on the day of the exam. (11) Smoking in last 4 hours from the exam.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of this study is to establish non-invasive method of treatment assessment using rotational thermography device, illumina360 and correlating the findings from thermographic breast images with standard imaging modalities such as USG (ultrasonography) and/or CT/ PET CT.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To characterize the breast tissue changes based on the difference in temperature pattern derived from thermographic breast images against the clinical and imaging findings ( USG/ CT/PETCT)as applicable.Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactDrBagyam Raghavan
Cura Healthcare Pvt.Ltd
Outcome results
None listed